Trb Chemedica International Sa
Clinical trials sponsored by Trb Chemedica International Sa, explained in plain language.
-
New eye drop BUFY01 takes on SVS20 in dry eye showdown
Symptom relief Recruiting nowThis study tests whether a new eye drop, BUFY01, works as well as an existing one, SVS20, for people with dry eye disease. About 80 participants will use one of the two drops daily for three months. Researchers will check eye health and ask about symptoms to see if the treatments…
Phase: NA • Sponsor: TRB Chemedica International SA • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC
-
New dry eye treatment put to the test against current standard
Symptom relief Recruiting nowThis study tests whether a new treatment (BUFY02) works as well as an existing one (TRB02) for dry eye disease. About 80 adults with dry eye for at least 3 months will use the assigned eye drops daily for 3 months. Researchers will check eye health and symptoms to see if both tre…
Phase: NA • Sponsor: TRB Chemedica International SA • Aim: Symptom relief
Last updated Jun 27, 2026 13:00 UTC